** Elevance's ELV.N shares rise 6.4% to $416.03 premarket
** Insurer beats Q4 profit estimates helped in part by lower-than-expected spending on medical care for its customers
** Company reports Q4 adjusted profit of $3.84 per share, beating estimates of $3.80 per share as per data compiled by LSEG
** Reports Q4 medical loss ratio — the percentage of premiums spent on medical care — of 92.4%, compared with analysts' estimates of 92.65%
** Stock had fallen 21.8% in 2024
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.